← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 1997Last known activity
Jul 1, 2024
Timeline
1990s
- Jan 1, 1995
AIDS Malignancy Consortium— Founded
Drugs by trial phase (100 distinct, 69 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 3 (13 own, 0 via acquisition)
Phase 2 (60 own, 0 via acquisition)
Phase 1 (16 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Adenocarcinoma
- Amyloidosis
- Anus Neoplasms
- Atherosclerosis
- Breast Neoplasms
- Burkitt Lymphoma
- Carcinoma
- Carcinoma, Adenosquamous
- Carcinoma in Situ
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinoma, Verrucous
- Castleman Disease
- Communicable Diseases
- Disease
- Erectile Dysfunction
- Esophageal Neoplasms
- Histiocytosis
- Histiocytosis, Langerhans-Cell
- HIV Infections
- Hodgkin Disease
- Hypereosinophilic Syndrome
- Hyperplasia
- IgG Deficiency
- Immunoblastic Lymphadenopathy
- Immunoglobulin Light-chain Amyloidosis
- Immunologic Deficiency Syndromes
- Infections
- Inflammation
- Intraocular Lymphoma
- Laryngeal Diseases
- Laryngeal Neoplasms
- Leukemia
- Leukemia, Hairy Cell
- Leukemia, Large Granular Lymphocytic
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia-Lymphoma, Adult T-Cell
- Leukemia, Mast-Cell
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Accelerated Phase
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
- Leukemia, Myeloid, Chronic-Phase
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Leukemia, Neutrophilic, Chronic
- Leukemia, Prolymphocytic
- Leukemia, T-Cell
- Lung Neoplasms
- Lymphoma
- Lymphoma, AIDS-Related
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Extranodal NK-T-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Large-Cell, Anaplastic
- Lymphoma, Large-Cell, Immunoblastic
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, Primary Effusion
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Lymphoma, T-Cell, Peripheral
- Lymphomatoid Granulomatosis
- Lymphoproliferative Disorders
- Multiple Myeloma
- Mycoses
- Mycosis Fungoides
- Myelodysplastic-Myeloproliferative Diseases
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Nasopharyngeal Carcinoma
- Neoplasms
- Neoplasms, Plasma Cell
- Oropharyngeal Neoplasms
- Papilloma
- Papillomavirus Infections
- Paranasal Sinus Neoplasms
- Penile Neoplasms
- Plasmablastic Lymphoma
- Plasmacytoma
- Polycythemia
- Polycythemia Vera
- Precancerous Conditions
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Primary Myelofibrosis
- Prostatic Hyperplasia
- Salivary Gland Neoplasms
- Sarcoma
- Sarcoma, Kaposi
- Sezary Syndrome
- Spondylarthritis
- Spondylarthropathies
Recent trials (50)
- NCT05797662Lead sponsorPhase 2Jul 1, 2024
- NCT05411237Lead sponsorPhase 3Dec 31, 2022
- NCT05389215Overall official - principal investigatorPhase 2Aug 30, 2022
- NCT04949464Overall official - principal investigatorN/AJul 1, 2022
- NCT04949464Lead sponsorN/AJul 1, 2022
- NCT04929028Overall official - principal investigatorPhase 2Feb 1, 2022
- NCT05077527Overall official - principal investigatorPhase 1Jan 31, 2022
- NCT05077527Lead sponsorPhase 1Jan 31, 2022
- NCT04577755Overall official - principal investigatorPhase 2Jun 12, 2021
- NCT04305691Overall official - principal investigatorPhase 2Nov 21, 2020
- NCT04305691Lead sponsorPhase 2Nov 21, 2020
- NCT04594850Overall official - principal investigatorPhase 2Oct 19, 2020
- NCT04139304Lead sponsorEarly Phase 1Nov 30, 2019
- NCT03797196Overall official - principal investigatorPhase 4Mar 31, 2019
- NCT03834571Lead sponsorPhase 2Mar 1, 2019
Details
- Founded
- Los Angelos, CA, US Jan 1, 1995
- Last known activity
- Jul 1, 2024
Notes
--- Pre-folding founded info: 1995-06-01 Los Angeles CA United States http://pub.emmes.com/study/amc/public/index.htm ---